SELLAS Life Sciences Group Inc (SLS)
1.17
-0.05
(-4.10%)
USD |
NASDAQ |
Nov 22, 16:00
1.165
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Net Income (Quarterly): -7.108M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -7.108M |
| June 30, 2024 | -7.47M |
| March 31, 2024 | -9.566M |
| December 31, 2023 | -8.136M |
| September 30, 2023 | -9.267M |
| June 30, 2023 | -8.84M |
| March 31, 2023 | -11.10M |
| December 31, 2022 | -9.121M |
| September 30, 2022 | -7.022M |
| June 30, 2022 | -8.414M |
| March 31, 2022 | -16.74M |
| December 31, 2021 | -6.598M |
| September 30, 2021 | -7.085M |
| June 30, 2021 | -4.613M |
| March 31, 2021 | -2.403M |
| December 31, 2020 | -3.716M |
| September 30, 2020 | -4.473M |
| June 30, 2020 | -4.425M |
| March 31, 2020 | -4.143M |
| December 31, 2019 | -7.419M |
| September 30, 2019 | -4.202M |
| June 30, 2019 | -3.134M |
| March 31, 2019 | -4.537M |
| December 31, 2018 | -13.32M |
| September 30, 2018 | -0.29M |
| Date | Value |
|---|---|
| June 30, 2018 | -6.062M |
| March 31, 2018 | -7.995M |
| December 31, 2017 | 2.443M |
| September 30, 2017 | -6.075M |
| June 30, 2017 | -5.913M |
| March 31, 2017 | -4.601M |
| December 31, 2016 | 0.352M |
| September 30, 2016 | -6.929M |
| June 30, 2016 | 5.389M |
| March 31, 2016 | -16.49M |
| December 31, 2015 | -19.68M |
| September 30, 2015 | -18.03M |
| June 30, 2015 | -15.66M |
| March 31, 2015 | -10.54M |
| December 31, 2014 | -7.956M |
| September 30, 2014 | -6.173M |
| June 30, 2014 | -19.94M |
| March 31, 2014 | -2.536M |
| December 31, 2013 | -48.50M |
| September 30, 2013 | -9.287M |
| June 30, 2013 | -9.597M |
| March 31, 2013 | -9.293M |
| December 31, 2012 | -3.751M |
| September 30, 2012 | -6.261M |
| June 30, 2012 | -0.196M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-16.74M
Minimum
Mar 2022
-2.403M
Maximum
Mar 2021
-7.383M
Average
-7.264M
Median
Net Income (Quarterly) Benchmarks
| Microbot Medical Inc | -3.215M |
| Alaunos Therapeutics Inc | -1.127M |
| Galectin Therapeutics Inc | -11.22M |
| Oragenics Inc | -2.463M |
| Anavex Life Sciences Corp | -12.21M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.329M |
| EPS Diluted (Quarterly) | -0.10 |
| Enterprise Value | 61.32M |
| Earnings Yield | -58.97% |
| Normalized Earnings Yield | -183.26 |